|
1
|
Nasim F, Sabath BF and Eapen GA: Lung
Cancer. Med Clin North Am. 103:463–473. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Võsa U, Vooder T, Kolde R, Vilo J,
Metspalu A and Annilo T: Meta-analysis of microRNA expression in
lung cancer. Int J Cancer. 132:2884–2893. 2013. View Article : Google Scholar
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu J, Bian T, Feng J, Qian L, Zhang J,
Jiang D, Zhang Q, Li X, Liu Y and Shi J: miR-335 inhibited cell
proliferation of lung cancer cells by target Tra2β. Cancer Sci.
109:289–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu YL, Sun Y, Zhou CC, Zhang L, Yu SY, Ma
SL, Han LL, Zhang XQ and Orlando M: Survival without common
toxicity criteria grade 3/4 toxicity following second-line
treatment with pemetrexed for nonsquamous non-small cell lung
cancer in Chinese patients. Chin Med J (Engl). 126:4624–4628.
2013.PubMed/NCBI
|
|
7
|
Woodard GA, Jones KD and Jablons DM: Lung
Cancer Staging and Prognosis. Cancer Treat Res. 170:47–75. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turchinovich A, Weiz L and Burwinkel B:
Extracellular miRNAs: The mystery of their origin and function.
Trends Biochem Sci. 37:460–465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barbato S, Solaini G and Fabbri M:
MicroRNAs in oncogenesis and tumor suppression. Int Rev Cell Mol
Biol. 333:229–268. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang X, Xu X, Ge G, Zang X, Shao M, Zou
S, Zhang Y, Mao Z, Zhang J, Mao F, et al: miR 498 inhibits the
growth and metastasis of liver cancer by targeting ZEB2. Oncol Rep.
41:1638–1648. 2019.PubMed/NCBI
|
|
11
|
Yuan J, Su Z, Gu W, Shen X, Zhao Q, Shi L,
Jin C, Wang X, Cong H and Ju S: MiR-19b and miR-20a suppress
apoptosis, promote proliferation and induce tumorigenicity of
multiple myeloma cells by targeting PTEN. Cancer Biomark.
24:279–289. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ganju A, Khan S, Hafeez BB, Behrman SW,
Yallapu MM, Chauhan SC and Jaggi M: miRNA nanotherapeutics for
cancer. Drug Discov Today. 22:424–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin K, Xu T, He BS, Pan YQ, Sun HL, Peng
HX, Hu XX and Wang SK: MicroRNA expression profiles predict
progression and clinical outcome in lung adenocarcinoma.
OncoTargets Ther. 9:5679–5692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee HY, Han SS, Rhee H, Park JH, Lee JS,
Oh YM, Choi SS, Shin SH and Kim WJ: Differential expression of
microRNAs and their target genes in non-small-cell lung cancer. Mol
Med Rep. 11:2034–2040. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin Z, Zhao J, Wang X, Zhu X and Gong L:
Overexpression of microRNA-497 suppresses cell proliferation and
induces apoptosis through targeting paired box 2 in human ovarian
cancer. Oncol Rep. 36:2101–2107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Akhurst T: Staging of non-small-cell lung
cancer. PET Clin. 13:1–10. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao L, Yan SB, Yang J, Kong JL, Shi K, Ma
FC, Huang LZ, Luo J, Yin SY, He RQ, et al: MiR-182-5p and its
target HOXA9 in non-small cell lung cancer: A clinical and
in-silico exploration with the combination of RT-qPCR, miRNA-seq
and miRNA-chip. BMC Med Genomics. 13:32020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Y, Min L, Ren C, Xu X, Yang J, Sun X,
Wang T, Wang F, Sun C and Zhang X: miRNA-148a serves as a
prognostic factor and suppresses migration and invasion through
Wnt1 in non-small cell lung cancer. PLoS One. 12:e01717512017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tan T, Xu XH, Lu XH and Wang XW:
MiRNA-200a-3p suppresses the proliferation, migration and invasion
of non-small cell lung cancer through targeting IRS2. Eur Rev Med
Pharmacol Sci. 24:712–720. 2020.PubMed/NCBI
|
|
22
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Li X, et al: microRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai H, Lin H, Cao W, Sun J, Huang Y and
Fang Y: The downregulation of miR-519a predicts poor prognosis and
contributes to tumor progression in gastric cancer. Int J Clin Exp
Pathol. 12:2496–2505. 2019.PubMed/NCBI
|
|
24
|
Shi X and Guan X: MicroRNA-99b predicts
clinical outcome of osteosarcoma and suppresses tumor cell
proliferation, migration and invasion. Diagn Pathol. 14:1172019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang H, Huang W, Wang Y, Ding L and Zeng
L: Overexpression of MiR-146a-5p Upregulates lncRNA HOTAIR in
triple-negative breast cancer cells and predicts poor prognosis.
Technol Cancer Res Treat. 18:15330338198829492019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gu GM, Zhan YY, Abuduwaili K, Wang XL, Li
XQ, Zhu HG and Liu CL: MiR-940 inhibits the progression of NSCLC by
targeting FAM83F. Eur Rev Med Pharmacol Sci. 22:5964–5971.
2018.PubMed/NCBI
|
|
27
|
Feng QQ, Dong ZQ, Zhou Y, Zhang H and Long
C: miR-16-1-3p targets TWIST1 to inhibit cell proliferation and
invasion in NSCLC. Bratisl Lek Listy. 119:60–65. 2018.PubMed/NCBI
|
|
28
|
Yao S, Hu M, Hao T, Li W, Xue X, Xue M,
Zhu X, Zhou F, Qin D, Yan Q, et al: MiRNA-891a-5p mediates HIV-1
Tat and KSHV Orf-K1 synergistic induction of angiogenesis by
activating NF-κB signaling. Nucleic Acids Res. 47:27002019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Xu L, He L, Wang J, Shi X, Li Z,
Shi S, Hou K, Teng Y and Qu X: MiR-891a-5p as a prognostic marker
and therapeutic target for hormone receptor-positive breast cancer.
J Cancer. 11:3771–3782. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu X and Lu J: The significance of
detection of serum miR-423-5p and miR-484 for diagnosis of
colorectal cancer. Clin Lab. 61:187–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kamarudin AN, Cox T and Kolamunnage-Dona
R: Time-dependent ROC curve analysis in medical research: Current
methods and applications. BMC Med Res Methodol. 17:532017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Enane FO, Saunthararajah Y and Korc M:
Differentiation therapy and the mechanisms that terminate cancer
cell proliferation without harming normal cells. Cell Death Dis.
9:9122018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cao W, Xu Y, Luo D, Saeed M and Sun C:
Hoxa5 promotes adipose differentiation via increasing DNA
methylation level and inhibiting PKA/HSL signal pathway in Mice.
Cell Physiol Biochem. 45:1023–1033. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li D, Bai Y, Feng Z, Li W, Yang C, Guo Y,
Lin C, Zhang Y, He Q, Hu G, et al: Study of promoter methylation
patterns of HOXA2, HOXA5, and HOXA6 and its clinicopathological
characteristics in colorectal cancer. Front Oncol. 9:3942019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu Y, Zhou T, Tang Q and Xiao J: HOXA5
inhibits tumor growth of gastric cancer under the regulation of
microRNA-196a. Gene. 681:62–68. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ordóñez-Morán P, Dafflon C, Imajo M,
Nishida E and Huelsken J: HOXA5 counteracts stem cell traits by
inhibiting Wnt signaling in colorectal cancer. Cancer Cell.
28:815–829. 2015. View Article : Google Scholar
|
|
37
|
Liu XH, Lu KH, Wang KM, Sun M, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chang CJ, Chen YL, Hsieh CH, Liu YJ, Yu
SL, Chen JJ and Wang CC: HOXA5 and p53 cooperate to suppress lung
cancer cell invasion and serve as good prognostic factors in
non-small cell lung cancer. J Cancer. 8:1071–1081. 2017. View Article : Google Scholar : PubMed/NCBI
|
